Melanoma Research Alliance
90 FOLLOWERS
Melanoma Research Alliance (MRA) is a leading funder of melanoma research, committed to accelerating scientific discovery and the development of new treatments and diagnostics for this deadly skin cancer.
Melanoma Research Alliance
2d ago
“Melanoma research helped lead the way to a lot of paradigm shifts in cancer treatment,” says Dr. Antoni Ribas, Professor of Medicine, Surgery, and Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA).  ..read more
Melanoma Research Alliance
2d ago
Renee Orcione, MRA Digital Engagement & Communications Manager | 21 March 2024 In Growing up as a child in the 2000s and even later into her teens and early 20s, Brittanny Groover wanted what many other young girls and women want: to be tan. Whether it was using tanning beds with her high school friends or laying out by the pool with her ..read more
Melanoma Research Alliance
3w ago
Good communication is always challenging but can be especially so when you are undergoing treatment for melanoma. That’s because navigating our modern healthcare system is often an exercise in decoding complex jargon and knowing the right questions to ask while managing stress and other strong emotions ..read more
Melanoma Research Alliance
3w ago
MRA’s 2024 Patient Forum brought together melanoma patients, survivors, advocates, and their loved ones to provide lay-friendly, state-of-the-science education and promote collaboration ..read more
Melanoma Research Alliance
3w ago
Renee Orcione, MRA Digital Engagement & Communications Manager | 28 February 2024 In In the five years since overcoming Stage 4 mucosal melanoma, Toni English has found her life’s passion advocating for patients and families and championing research to answer the many questions that surround this rare melanoma ..read more
Melanoma Research Alliance
1M ago
The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to approve Iovance Biotherapeutics’ AMTAGVITM (lifileucel) for the treatment of patients with advanced melanoma in the second line treatment setting ..read more
Melanoma Research Alliance
1M ago
Tanisha Jackson, PhD - MRA Scientific Program Director | 5 February 2024 In Immune-related adverse events (irAEs) are side effects experienced by patients undergoing immunotherapy to treat their melanoma (or other cancer). In November, at the annual Society for Immunotherapy of Cancer (SITC) meeting, we spoke with Dr. Alexandra-Chloé Villani, an MRA-funded investigator at Massachusetts General Hospital, to learn more about immune-related adverse events and the research she leads in this area ..read more
Melanoma Research Alliance
2M ago
Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 22 January 2024 In Ten years ago, Sean Wachter never expected to have a loving spouse, children, or a life that feels worth living. That’s because, by his own admission, he’s done more living in the past 7 years than he did in the prior 31 as he overcame stage 4 melanoma with leptomeningeal disease ..read more
Melanoma Research Alliance
2M ago
MRA is a world leader in advancing transformational science that has caused paradigm shifts in what it means to be diagnosed with and treated for melanoma. The innovative research we support isn’t just changing science — it’s giving patients more treatment options that translate to longer, fuller lives ..read more
Melanoma Research Alliance
2M ago
Joan Levy, PhD - MRA Chief Science Officer | 26 January 2024 In Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for ..read more